
-
Leo XIV, the 'Latin Yankee', to celebrate first mass as pope
-
Most stocks lifted by hopes for US-China talks after UK deal
-
IPL suspended indefinitely over India-Pakistan conflict: reports
-
German lender Commerzbank's profits jump as it fends off UniCredit
-
Rare bone-eroding disease ruining lives in Kenya's poorest county
-
India says repulsed fresh Pakistan attacks as de-escalation efforts grow
-
Zhao's historic snooker title sparks talk of China world domination
-
'High expectations': EU looks to Merz for boost in tough times
-
Poisoned guests rarely invited before deadly mushroom lunch, Australia trial hears
-
China sales to US slump even as exports beat forecasts
-
Indian cricket to make 'final decision' on IPL over Pakistan conflict
-
Dethroned Bundesliga champions Leverkusen face uncertain future
-
China can play hardball at looming trade talks with US: analysts
-
French monuments in trouble while PSG prepare for Champions League final
-
Newcastle face Chelsea in top five showdown, Alexander-Arnold in spotlight
-
Flick's Barca must show 'hunger' in crunch Liga Clasico
-
Clasico the last chance saloon for Ancelotti's Real Madrid
-
Timberwolves overpower Warriors to level series
-
Chinese fabric exporters anxious for US trade patch-up
-
Putin gears up to host world leaders at lavish army parade
-
Nearing 100, Malaysian ex-PM Mahathir blasts 'old world' Trump
-
Leo XIV, first US pope, to celebrate first mass as pontiff
-
Asian stocks lifted by hopes for US-China talks after UK deal
-
Former head of crypto platform Celsius sentenced 12 years
-
Ex-model testifies in NY court that Weinstein assaulted her at 16
-
Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update
-
Argo Blockchain PLC Announces 2024 Annual Results and Restoration of Listing
-
'Great honor': world leaders welcome first US pope
-
Pacquiao to un-retire and fight Barrios for welterweight title: report
-
Trump unveils UK trade deal, first since tariff blitz
-
Man Utd one step away from Europa League glory despite horror season
-
Jeeno shines on greens to grab LPGA lead at Liberty National
-
Mitchell fires PGA career-low 61 to grab Truist lead
-
AI tool uses selfies to predict biological age and cancer survival
-
Extremely online new pope unafraid to talk politics
-
Postecoglou hits back as Spurs reach Europa League final
-
Chelsea ease into Conference League final against Betis
-
Pope Leo XIV: Soft-spoken American spent decades amid poor in Peru
-
First US pope shared articles critical of Trump, Vance
-
'Inexcusable' - NBA champs Boston in trouble after letting big leads slip
-
US automakers blast Trump's UK trade deal
-
Stocks mostly rise as US-UK unveil trade deal
-
Trump presses Russia for unconditional 30-day Ukraine ceasefire
-
Anything but Europa League glory 'means nothing' for Man Utd: Amorim
-
'Inexcuseable' - NBA champs Boston in trouble after letting big leads slip
-
Pope Leo 'fell in love with Peru'and ceviche: Peru bishop
-
Pakistan's T20 cricket league moved to UAE over India conflict
-
India tells X to block over 8,000 accounts
-
Germany's Merz tells Trump US remains 'indispensable' friend
-
Ex-model testifies in NY court that Weinstein assaulted her as a minor

Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
C.Garcia--AMWN